Addressing Broader Health Concerns Related to GLP-1 Drugs So far, researchers have only studied GLP-1 drugs in randomized clinical trials in the context of diabetes and obesity
What to Expect in Months 7-11 Essentially no side effects: Appetite suppression continues (desired effect), but GI symptoms gone Weight loss velocity slows: From 0.8kg/week (months 3-6) to 0.3-0.5kg/week Plateau around week 40-48: Weight stabilizes, no longer losing despite continued medication Total weight loss: Average 20-24% from baseline (matching or exceeding surgical outcomes) Focus shifts to maintenance: Accepting current weight, preventing regain Plateau frustration: Not a side effect but an emotional challenge 2 Final Strategies for Months 7-11 20
Elimination Half-Life of Drugs
Allow vial to equilibrate before opening to prevent condensation
Like any powerful treatment, it can come with side effectsbut with the right support, those side effects are often short-lived and manageable
The jump from 4mg to 8mg added another 5.7 percentage points, reaching 22.8%
)
